Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

DDO-8958

SKU: orb2944494

Description

DDO-8958 is a potent, orally bioavailable, and selective BET BD1 inhibitor with a 5.6 nM KD for BRD4 BD1. It exhibits robust anti-cancer activity in vitro by inhibiting proliferation and migration, inducing apoptosis and cell cycle arrest, and has demonstrated antitumor efficacy in vivo.

Research Area

Cell Biology, Epigenetics & Chromatin, Metabolism Research

Images & Validation

Key Properties

CAS Number3017180-18-3
MW407.441
FormulaC22H22FN5O2
SMILESFC=1C(=CC(OCC2COC2)=CC1C=3C(=NN(C3C)C)C)C4=CC=NC=5N=CNC54
TargetApoptosis,Epigenetic Reader Domain

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information